NovaBay Pharmaceuticals Inc (NBY)

NBY on American Stock Exchange

0.54USD
27 Feb 2015
Change (% chg)

$0.02 (+3.85%)
Prev Close
$0.52
Open
$0.45
Day's High
$0.55
Day's Low
$0.42
Volume
241,957
Avg. Vol
--
52-wk High
$1.38
52-wk Low
$0.42

NBY

Chart for NBY

About

NovaBay Pharmaceuticals, Inc. (NovaBay) is a clinical-stage biotechnology company focused on addressing the unmet therapeutic needs of the global anti-infective market. The Company’s Aganocide compounds, led by NVC-422, are patented, synthetic molecules with a spectrum of activity against bacteria, viruses and fungi. The Company... (more)

Overall

Beta: 0.60
Market Cap(Mil.): $28.39
Shares Outstanding(Mil.): 51.63
Dividend: --
Yield (%): --

Financials

  NBY Industry Sector
P/E (TTM): -- 175.70 40.21
EPS (TTM): -0.32 -- --
ROI: -166.32 -2.61 16.34
ROE: -267.51 -4.38 17.27
Search Stocks

Competitors

  Price Chg
PuriCore plc (PURI.L) 30.50p 0.00
C R Bard Inc (BCR.N) $169.14 -1.80
Smith & Nephew plc (SN.L) 1,186.00p +5.00
Abbott Laboratories (ABT.N) $47.37 -0.24
GlaxoSmithKline plc (GSK.L) 1,541.50p -12.50
3M Co (MMM.N) $168.65 -0.96
Sanofi SA (SASY.PA) €87.70 +0.16
Pfizer Inc. (PFE.N) $34.32 -0.27
Novartis AG (NOVN.VX) CHF97.45 -0.70
Johnson & Johnson (JNJ.N) $102.51 -0.29

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks